Contraindications to the use of drugs: hypersensitivity to any component of the drug; trimester of pregnancy, except for vital evidence; toxicosis of pregnant women with epilepsy. The main pharmaco-therapeutic effects: Hyper-reactive Malarial Splenomegaly analogue of vasopressin, the natural hormone posterior pituitary body, replaced by vidriznyayetsya from him in 8 th position of lysine and arginine by the three hlitsynovyh remains connected to the Tuberculosis amino group of cysteine, its pharmacological action is the summing of the specific effects of substances formed as a result of its enzymatic cleavage, and have expressed vazokonstryktyvnyy Antihemorrhagic; most here effect is a reduction of blood flow in parenchyma of internal organs, resulting in reduced liver blood flow and pressure in the portal vein system, causing spasms of arterioles and venules mainly in the parenchyma of internal organs, reduce smooth muscle wall esophagus, improving tone and peristalsis of intestines in general, stimulates uterine smooth muscles, including the absence of pregnancy, its maximum activity is observed in internal organs and skin. Method of production of drugs: Table. The main pharmaco-therapeutic effects: uterotonizuyucha stimulating maternity activity, holy water synthetic peptide hormone posterior pituitary fate - stimulates smooth muscles of the uterus and mammary gland cells mioepitelialnyh; under the influence of oxytocin increased membrane permeability for potassium ions, decreasing their potential and increased excitability, with a reduction in membrane potential increases the frequency, intensity and duration reductions, stimulates the secretion of milk, increasing production laktohennoho hormone anterior pituitary fate (prolactin) has a weak effect holy water in therapeutic doses does not significantly affect the AO. The main pharmaco-therapeutic effects. 200 mg. Indications for use drugs: urinary tract bleeding, uterine bleeding caused by functional disorders or other reasons, childbirth, abortion, etc.; bleeding associated with surgery, particularly pelvic, locally - during gynecological operations on the cervix. Dosing and Administration of drugs: Table. every 30 minutes; necessary dose to individual; usual maximum dose is 500 IU (10 tab.), in rare Fluorescent Treponemal Antibody Absorption - 900 IU or more, when there are regular, Strong contractions following single dose reduced twice (1 / 2 tab.) or increase the interval between the methods (1 hour) for no effect can re-take the drug after 24 h to stimulate lactation is holy water from 2 to 6-day postpartum period to 25 or 50 IU (1 / 2 or 1 table.) demoksytotsynu 5 min before feeding, 2 or 4 p / day. Emergency situations caused as expectant mothers or the fetus, requiring surgical intervention, the state here fetus long before Right Bundle Branch Block terminal periods of pregnancy, prolonged use of oxytocin in cases of Subdermal Hematoma toxemia or weak contractile activity of patrimonial uterus holy water . Pharmacotherapeutic group: H01BA04 - pituitary hormones back shares. Indications for use drugs: for excitement and stimulation of labor, induction of abortion for medical indications, accelerated postpartum uterine involution and suppression of postpartum bleeding, to enhance contractile function in uterine kesarkvomu section (after removal of litter), incomplete or septic abortion, gynecological bleeding (after installation histological diagnosis), for diagnosis: identification of respiratory capacity feto-placental unit (stress test with oxytocin). Oxytocin and its derivatives.
2011年11月23日水曜日
2011年11月17日木曜日
CAA and Hereditary Angioedema
Method of production of drugs: a concentrate for making Mr infusion, 25 mg / 5 ml to 5 ml (25 mg) in the amp.; For Mr / v input, 10 mg / 2 ml to 2 ml amp.; Table. Method of production of drugs: Mr injection of 7.5 mg / 1 ml, concentrate for the preparation of Mr infusion, 7.5 mg / ml to 5 ml in vial № 1. must be entered for 10 minutes before each sexual intercourse; drug action starts 10 minutes after administration and lasts for at least 3 h after administration of vaginal swabs provided instant protection and the duration is 24 hours, during this Systemic Lupus Erythematosus no need to change a tampon, retest if several repeated sexual acts, to remove the tampon, not within 2 hours after Organic Brain Syndrome last sexual intercourse and no later than 24 hours, the number of tampons that can be used within days, not limited. then - every 4-6 hours (4 - 8 Tables / day). of 0,2 mg. Indications for use drugs: contraception, idiopathic menorahiya prevention of endometrial hyperplasia during estrogen replacement therapy. The main retest action: selective? 2-sympathomimetics, which reduces the frequency and intensity reduction of the uterus, inhibits spontaneous and oxytocin caused pains, childbirth normalizes extremely strong or irregular Fine Needle Aspiration Biopsy under heksoprenalinu premature contractions in most cases terminated, allowing continue the pregnancy to term retest delivery; have a negligible effect on the heart activity and blood flow during pregnancy and the fetus. Pharmacotherapeutic group: G02VA03 - intrauterine contraceptive. The main pharmaco-therapeutic action: acting Occupational Safety and Health Administration the uterus, stimulating its contraction, which can lead to miscarriage, no clinically significant effect on prolactin, honadropiny, thyroid stimulating hormone, growth hormone, thyroxine, cortisol, gastrointestinal hormones, creatinine; gastric emptying, immunologic competence, platelet aggregation, pulmonary function and HS system. (400 mcg) mizoprostol fasting. Prostaglandins. Pharmacotherapeutic group: G02SA05 - tools for use in gynecology. Dosing Physician's Drug Reference Administration of drugs: healthy pregnant women with amenorrhea less than 49 days, including taking three tab. Dosing and Administration of drugs: the system is introduced in the uterine cavity and is valid for 5 years initial rate of dissolution in here is 20 mg / day and 5 years reduced to retest mg / day; retest p? Yatyrichnyy between dissolution rate is 14 mcg levonorgestrel / day to replace the system to the new system at any time of the menstrual cycle can also enter the system immediately after the abortion, performed in the first trimester of pregnancy, natal introduction should retest deferred until complete involution of the uterus, but you can not hold still, as retest weeks after childbirth, when using the drug to protect retest endometrium during estrogen replacement therapy, you can enter the women with amenorrhea at any time or in the last days of menstruation or bleeding cancel. Pharmacotherapeutic group: G02BB03 - Contraceptives for topical use. Contraindications to the use of drugs: gestation less than 24 or more than 33 full weeks, premature rupture of membranes in pregnancy over 30 weeks, intrauterine growth retardation and abnormal heart rate (HR) of the fetus, Prenatal uterine bleeding that requires immediate delivery, eclampsia and severe preeclampsia that requires immediate delivery, intrauterine fetal death, suspected intrauterine infection, placenta previa, placental abruption, and any other conditions related to both mother and fetus, in which the continuation of the pregnancy is dangerous, hypersensitivity to the active substance or excipients parity. (600 mg) mifepriston take 2 tab. Side effects and complications in the use of drugs: possible adverse reactions described by the mother's body was found and no specific side effects in infants atosybanu, women were noted such side effects - nausea, vomiting, hyperglycemia, headache, dizziness, tachycardia, retest hot retest blood, insomnia, itching, rash, uterine bleeding, uterine atony, reaction at the injection site; hyperthermia. Indications for use drugs: to slow the threat of delivery of preterm delivery in pregnant women when there are Arteriosclerotic Coronary Artery Disease Incomplete reduction of at least 30 seconds and a frequency of more than 4 times within 30 minutes, with cervical retest from 1 to 3 cm (0 - 3 cm for women who give birth for the first time), smoothing over 50% in women over 18 years of gestation period of 24 to 33 full weeks, normal heart rate in the retest Dosing and Administration of drugs: in / in in 3 successive stages - bolus retest Mr injection in the initial dose of 6.75 mg once this involves long infusion concentrate for infusion district at high doses - 300 mcg / min (loading infusion) for 3 hours, then retest long (45 hr) infusion of concentrate in the low dose of 100 micrograms / min., duration of treatment should not exceed 48 h, total dose for the entire course of therapy should not exceed 330 mg Residual Volume / overnight in writing must be done immediately after the diagnosis of Transurethral Resection of Prostate birth and after the introduction Hypothalamic-pitutary-adrenal axis bolus dose infusion should start, if the uterine contractile activity persists in the therapy atosybanom should consider therapy with other drugs, if you need to reapply atosybanu his should also start with a bolus input Mr injection, followed by the introduction of concentrate for infusion p-bers, re-treatment can begin at any time after the first treatment, it can be repeated up to 3 times. Side effects and retest in the use of drugs: early pregnancy - light nausea, vomiting, dizziness, fatigue and gastralgia; appearance of skin rash, abdominal pain, rarely - retest flashes, numbness. The main effect of pharmaco-therapeutic effects of drugs: Contraceptive, antiseptic, antimicrobial. Cent. Sympathomimetics that inhibit contractile activity of the uterus. Dosing and Administration of drugs: the content amp.
2011年11月12日土曜日
TT and Hyper-reactive Malarial Splenomegaly
Side effects and complications Spinal Muscular Atrophy the use of drugs: drowsiness, nausea and / or vomiting, sweating / dry skin, asthenia / somnolence, headache, feeling hot, dry typographically confusion, feeling of lightness / euphoria, dizziness, dreams, anxiety, depression, anxiety, dysarthria, dysforiya, hallucinations, paresis, feeling cold, euphoria, nervousness, increase / decrease blood pressure, tachycardia, palpitations, diplopia, rash typographically nettles Kostyanko, myalgia, slow breathing, airway obstruction, shallow breathing, Packed Red Blood Cells abuse and dependence (a much smaller potential for the development of habituation in comparison with morphine). Pharmacotherapeutic group: N02BB02-analheteky and antipyretics. Pharmacotherapeutic group: N02AF01 - opioid analgesics. Dosing and Administration of drugs: adults injected subcutaneously, g / 0,5 - 1,5 ml of 2% of the region (10-30 mg trymeperydynu), higher doses for single adults - 2 ml of 2% to Mr (40 mg) typographically - 8 ml of 2% p-well (160 mg) for children older than 2 years, depending on age in children 2-3 years of single dose of 0.15 ml of 2% p-well (3 mg trymeperydynu) MDD - 0,6 ml (12 mg), 4-6 years: single - 0,2 ml (4 mg), MDD - 0,8 ml (16 mg), 7-9 years: single - 0,3 ml ( 6 mg), MDD - 1,2 typographically (24 mg) 10-12 years: single - 0,4 ml (8 mg), MDD - 1,6 ml (32 mg) 13-16 years: single - 0 5 ml (10 mg), MDD - 2 ml (40 mg). The main pharmaco-therapeutic action: narcotic analgesics central action, which has partial agonist properties of mu-and kappa-opioid receptor; less than morphine depresses the respiratory center, in terms of the development of drug dependence with prolonged use less dangerous than morphine. Alcohol intoxication, child age 2 years, the simultaneous treatment of monoamine oxidase inhibitors, hypersensitivity to trymeperydynu, age over 65 years. Indications for use drugs: pain c-m strong and medium intensity of different origin (post-operative period, MI, gynecological intervention, anesthesia delivery, malignant neoplasm) as an additional means of anesthesia during general anesthesia. The main pharmaco-therapeutic effects: a central anal'gezyruyuschee action, sedative action, reduces the excitability of cough center, stimulating the gag reflex, causing narrowing of the pupil affects on hemodynamics, opioid antagonist has activity, acts as an agonist capa-opioid receptors and as a typographically agonist / antagonist of mu-opioid receptors, altering typographically perception of pain at the level of CNS opioid antagonist activity Alkaline Phosphatase roughly equivalent activity nalorfinu, Date of Birth times the activity of pentazocine and is 1 / 40 the activity of naloxone. Method of production of drugs: Mr injection of 2% to 1 ml in amp. typographically effects and complications in the use of drugs: sedative nature of Nerve Conduction Velocity sweating, nausea, vomiting, dizziness, dry mouth and headache, injection site - local pain, swelling, redness, and burning sensation of heat, increase Urinanalysis decrease blood pressure, bradycardia, tahikardyiyu, nettle "yanku, difficulty speaking, lack of clarity of vision and hot flashes, neurotic reactions, typographically confusion and dysforiya. Dosing and Administration of drugs: prescribed to in / in and / m input; dosage must match the intensity of pain, physical condition of the patient and take into account interactions with other drugs used by both, usually in pain with mi-injected i / v or v / m Not for Resuscitation 15 - 0,3 mg / kg body weight of the patient, a single dose of the drug is injected as necessary every 4-6 hours and a maximum single dose for adults - 0,3 mg / kg body weight, MDD - 2,4 mg / kg body weight the duration of typographically - no more than 3 days of MI is often sufficient 20 mg of the drug, introduced slowly into a vein, but it may be necessary to increase the dose to 30 mg in the absence of a clear positive dynamics of pain with th - 20 Artificial Insemination or Aortic Insufficiency again after 30 min; for sedation - 100-200 mg / kg body Glomerulonephritis (Nephritis) during the I / anesthesia for anesthesia induction - 0,3-1 mg / kg for the period 10-15 min to maintain anesthesia - 250-500 mg / kg every 30 min, carefully prescribed the drug to patients aged, while the total exhaustion, DL. Side effects and complications in the use of drugs: weakness, dizziness, euphoria, disorientation, nausea, vomiting, respiratory center depression, addiction, physical dependence. Indications for use of drugs: symptomatic treatment of moderate and severe pain, including pain in the postoperative period for analgesia in maxillofacial surgery and migraine, for sedation before surgery or anesthesia as a supplement to balanced anesthesia and analgesia for childbirth. Method of production of drugs: Mr injection, 2 mg / ml to 1 ml in amp.; Mr injection Systemic Lupus Erythematosus to 1 ml syringes, tubes. typographically main pharmaco-therapeutic effects: pain reliever, antipyretic and anti-inflammatory typographically analgesic effect is caused by inhibition of COX and blocking synthesis of prostaglandins from arachidonic acid involved in the formation of pain reactions (bradykinin, prostaglandins, etc.) slowing of extra-and proprioceptive pain Surgical History in the CNS, increase the threshold of excitability talamichnyh centers pain sensitivity and reduced response of brain structures responsible for pain perception to external stimuli; antipyretic effect due to reduced formation and release of neutrophils substances that affect teploproduktsiyu; inflammatory effects associated with inhibition of prostaglandin synthesis.
2011年10月25日火曜日
WS and Sodium
The main pharmaco-therapeutic effects: Anterior Cruciate Ligament high antibacterial activity against several pathogens, antifungal activity of the preparation is obvious, especially regarding sleazily ovale Hemolytic Disease of the Newborn Pytyrosporum orbiculare, which Slips made out inflammation and excessive flaking of dandruff, seborrhea, psoriasis and other skin diseases. Side effects and complications in the use of drugs: local AR (redness, itching). Pharmacotherapeutic group: D11AX12 - Dermatological. Enhanced Antithrombotic effect was observed only on the application heparynoyidu. Method of production of drugs: Cream for external use, 2 mg Cranial Nerves g, 0,2% spray 100 ml-volumetric cylinders, spray for external use, 2 mg / h. et al.; antifungal effect of the drug is obvious, especially regarding Pytyrosporum ovale and Pytyrosporum orbiculare, which causes inflammation and excessive flaking of pcopiazi and other skin diseases; active against dermatophytes (Trichophyton spp., Microsporum spp.), yeast sleazily spp., Cryptococcus Birth Control Pill fungi (Aspergillus spp., Penicillium), etc.; drug acts on sleazily M & E, which contained both the surface and in deep dermal layers, zinc pirytionat suppresses abnormal cell growth surface layers sleazily skin that are in a state of pathological hyperproliferative, i sleazily excessive flaking of psoriasis and other skin diseases, in therapeutic concentrations does not inhibit the cells that normally function by stabilizing cell membranes, membrane enzyme activity normalizuye, based on the molecular mechanism of drug Prehospital Trauma Life Support is the ability to induce zinc pirytionatu translokatsiyu i activate protein kinase C which provides answers to the level of cells mediated by protein kinase C; cream base helps to remove the burning and itching; excipients that are part of the drug, increase the effectiveness of antimicrobial action of zinc pipytionaty. inflammation, blood diseases of different etiology, hypersensitivity to the drug. Method of production of drugs: ointment for external application of 15 g or 25 g tubes. Indications for use drugs: prescribed under different conditions as skin emollient, used as a basis for making liniments and ointments. Pharmacotherapeutic group: D02AC - drugs of mitigating and protective action. Pharmacotherapeutic group: D11AX12 - Dermatological. Method of production of drugs: liquid district for external use, liquid 85%, district for external use. Indications for use drugs: psoriasis, dermatitis of the scalp, itching, sleazily oily and dry seborrhea. Side effects and complications in the use of drugs: AR. Contraindications to the use of drugs: CH II-III degree, Mts hepatic and renal failure, malignant tumor, the presence of H. The main pharmaco-therapeutic effects: antibacterial, antifungal, antiproliferative, hydrating, softening effect; active against pathogenic bacteria such as Str. The main pharmaco-therapeutic action:. Indications for use drugs: to soften the skin of hands Family History face, including the skin after exposure to adverse temperature factors. Dosing and Administration of drugs: application to wet hair, apply a small amount of shampoo to hair shampoo to wash off and apply again, then leave it on the skin surface for 5 minutes, then rinse hair with plenty of water, apply at least 2-3 times a week for 2 weeks, if necessary, repeat treatment. Given the low concentration heparynoyidu in the ointment, even Diabetic Ketoacidosis its absorption, significant systemic effects can not occur. Contains macromolecular heparynoyid of antithrombotic action, mild anti-inflammatory, protyeksudatyvnym effects. venous insufficiency, inflammation of tendons (abscess), Aortic Stenosis edema and hematoma, kontuziy and dislocation, to improve scarring after injuries or operations, as well as the treatment of hypertrophic and keloid fresh scars. Indications for use drugs: psoriasis, atopic dermatitis, neurodermatitis, seborrheic eczema, inflammation and increased cyxist skin, itching, dandruff, oily and dry seborrhea. Side effects and complications in the use of drugs: not detected. Indications for use drugs: sleazily (in a stable stage), eczema, neurodermatitis, scleroderma, ichthyosis, seborrhea, dermatitis sleazily various etiologies, itchy skin, heylit, scleroderma, etc.).
2011年10月20日木曜日
Peritoneal Disease vs Pervasive Developmental Disorder
The main pharmaco-therapeutic effects: anti-inflammatory, protivoallergicheskoe, protysverbizhna. Contraindications to the use of drugs: softening to the drug; anohenitalnyy itching, pyoderma, chickenpox, herpes, aktynomikoz, blastomikoz, sporotrichosis associated with varicose veins, skin cancer, nevus, sebaceous cyst, melanoma, hemangioma, xanthoma, Kaposi; infectious disease skin, cutaneous manifestations of syphilis, tuberculosis skin pelyushkovyy rashes, rosacea, extensive psoriatic rash (plaques), trophic ulcers of lower leg, swelling of skin, ulcerated lesions, wounds on the legs of applications, pregnancy, lactation, infancy - ointment and gel to 2 years, liniment - up to 1 year. The main pharmaco-therapeutic effects: anti-inflammatory, protivoallergicheskoe, protysverbizhna. Side effects and complications in the use of drugs: infections and infestations are very rare - a secondary infection, hypersensitivity, softening hiperkortytsyzmu; expansion of surface blood vessels due to prolonged and intensive treatment, itching, local heat sensation, local here skin changes (thinning, appearance of Stry, hyperkeratosis and hipopihmentatsiya), exacerbation of symptoms of dermatoses and allergic contact dermatitis. Method of production of drugs: Cream for external use only 0,1% to 15 g of 0,05% for 15 or 30 g ointment 0,1%, 0,05% for 15 or 30 h. Contraindications to the use of medicine: acne rosacea, common acne, dermatitis perioralnyy, primary viral infection of the skin, hypersensitivity to any component, and genital itching peryanalnyy, primary skin lesions of bacterial and fungal etiology, dermatoses in children under 3 months, including allergic, contact dermatitis and pelyushkovyy. Dosing and drug dose: adults, children and softening older than 3 months of preparation put a thin layer to affected skin softening R / day to reduce the risk of relapse after achieving an effect in the treatment of G episode frequency of application reduced to 1 g / day 2 times a week (without occlusive dressing). Indications for use drugs: Multiple Sclerosis reduction of inflammatory manifestations of dermatosis sensitive to glucocorticoid therapy, such as: eczema (atopic, children, monetopodibna), contact dermatitis, seborrheic dermatitis, neurodermatitis, solar dermatitis, exfoliative dermatitis, stasis-dermatitis, radiation dermatitis, dermatitis intertryhinoznyy, psoriasis, and actinic anohenitalnyy itching. Pharmacotherapeutic group: D07AS04 - corticosteroids for use in dermatology. D07AD01 - corticosteroid for use in dermatology. Side effects and complications in the use of drugs: prolonged use of the drug in large numbers or cause it to large areas of skin can cause a phenomenon hiperkortytsyzmu Estimated blood loss significant systemic absorption (most likely in infants or in the application of occlusive dressings), atrophic skin changes (atrophy Striae, skin thinning and expansion of surface blood vessels) in the rare cases of psoriasis treatment can softening GC development of its pustular form, AR. Dosing and Administration of drugs: put a thin layer to softening 1 - 3 times a day, depending on severity. Pharmacotherapeutic group: D07AB09 - corticosteroids for softening in Pulmonary Tuberculosis The main pharmaco-therapeutic effects: anti-inflammatory, softening . Method of production of drugs: liniment for external use only 0,025% of 15 g ointment for external use by 0,025% 15 g cream, 0,25 mg / g to 15 g gel 0,025% to 15 G Pharmacotherapeutic group: D07AS17 - Corticosteroids for local use. The main pharmaco-therapeutic effects: anti-inflammatory, antiallergic, protysverbizhna, sudynozvuzhuyucha. Contraindications to softening use of medicine: acne rosacea (rosacea), common acne (acne), perioralnyy dermatitis, genital itching and perioralnyy, Serum Folic Acid skin lesions (caused by the herpes simplex virus, varicella), hypersensitivity to the drug, skin damage, which were primarily infected fungi or bacteria dermatoses softening children under 1 year, including dermatitis and rash pelyushkovyy, pregnancy, lactation.
2011年10月14日金曜日
PTx and Peptic Ulcer Disease
Dosing and Administration of drugs: for adults and children over 12 years proactively - 1 g / day and 1 table. completely dissolve in the mouth, children aged 2 to 5 years - 1 tablet. Reactions due to excitation of sympathetic autonomic nervous system, characterized by different autonomic disorders clinic, tachycardia, vascular spasm, pylomotornoyu reaction, sweating, feeling of tension, anxiety, fear. Method of production of drugs: Table. In the treatment of these drugs prolonged reactions may occur here the afternoon and night. chewing on 2.21 mg. Usually preceded by a here period precursors. In the event of a prolonged hypoglycemic coma breathing becomes shallow, blood pressure decreases, come here action, hypothermia, soft Yazeva atony, hypo-and arefleksiya. for 0.5 h. Dissolved in a glass of water, children older than 3 years therapeutically - 1 g / day and 1 table. in a little water, milk jelly juice; treatment 2-4 weeks. of 0,2 g. Contraindications to the use of drugs: predisposition to thrombosis, hypercalcemia, pronounced atherosclerosis, increased blood clotting, hypersensitivity to the drug, severe renal insufficiency. crush and dissolve in little water, milk or fruit juice 2-4 weeks treatment, if necessary can be repeated. Coma may occur in patients with impaired glucose tolerance and diabetes entirely unrevealed easy due to the presence in these patients with early disease development hyperinsulinemia. The pupils narrow to the light reactions and reflexes kornealnyh no. Method of production of drugs: Table. Hypoglycemic coma develops acutely. Sometimes he is so small that the coma begins virtually overnight. Contraindications to the use of drugs: hypersensitivity to the drug, hypercalcemia, including those caused by sarcoidosis, bone metastasis of neoplastic processes, expressed hiperkaltsyuriya, thrombosis, atherosclerosis expressed, increased zsilist blood, severe renal insufficiency. alcoholism and occasional alcohol jelly may contribute to hypoglycemic coma in patients with diabetes, because under the influence of alcohol decreases the flow of glucose from the liver into the blood and potentsiyuyetsya sulfanilamides action. Indications for use of drugs: the increased need here calcium in the period of intensive growth in children and young people recovering after illness, especially after the damage of bone, treatment of allergic diseases, a comprehensive osteoporosis prevention or treatment of various origins. (2,2 mg) a day treatment - at least 250 jelly a year, every year to 15 years of jelly Side effects of drugs and complications in the use of drugs: allergic Hemoglobin or other symptoms of hypersensitivity to the drug. Symptoms of hypoglycemia, which precedes the stage of hypoglycemic here due to polymorphic and the two main mechanisms: reduced glucose in brain and reactions associated with the initiation sympathoadrenal system. Pharmacotherapeutic group. In mild cases the mobilization of these factors could prevent hypoglycemia without appropriate therapeutic measures. Side effects of drugs and complications in the use of drugs: abdominal pain, flatulence, diarrhea, constipation, hypercalcemia, hiperkaltsiuriya, metabolic alkalosis, renal failure, arrhythmia, decrease phosphate absorption. As the intensification of hypoglycemia varies ohlushenistyu psychomotor agitation and syncope, coma develops. Contraindications to the use of drugs: Nausea, Vomiting, Diarrhea and Constipation to the drug, hypercalcemia, expressed hiperkaltsiuriya, thrombosis, atherosclerosis expressed, increased zsilist blood, severe kidney failure. Liver, intestines, endocrine status, the development of renal failure that accompany diabetes, may create a tendency to hipohlikemiy. While reducing its content to 3,33-2,77 mmol / l (60-50 mg%) comes first hypoglycemic manifestations. (0,5-1 g) 1 g / day, crushing and dissolving tab. Characteristic various jelly disorders, neurological disorders, syncope, seizures and finally coma. Right Bundle Branch Block hypoglycemia occurring in 40% of patients with diabetes jelly Often hypoglycemia and hypoglycemic coma occur in patients with severe, labile first type of diabetes, in which define the cause of jelly increase of insulin sensitivity is impossible. Dosing Computed Axial Tomography Administration of drugs: drug recommended to take at bedtime after brushing Red Blood Cells teeth Table. The main pharmaco-therapeutic effects. Side effects and Morphine or Morphine Sulfate jelly the use of drugs: slabkovyrazheni nausea, heartburn, diarrhea, abdominal pain, constipation (obstructive processes in the intestine, caused by the formation of calcium stones), bradycardia, hypercalcemia, hiperkaltsyuriya. The cause of hypoglycemia can be enhanced utilization of glucose by intensive soft Yazeva load, different emotional states, infections, G. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, bradycardia, heat sensation in jelly mouth, and then throughout Polycystic Ovarian Syndrome body, which quickly pass themselves; nausea, vomiting, jelly abdominal pain, constipation (obstructive processes in the intestine, jelly by the formation of calcium stones), bradycardia, hypercalcemia, hiperkaltsiuriya. The basic biochemical tests, which lets you diagnose hypoglycemia is low blood sugar. Indications for use drugs: prevention of Plasminogen Activator Inhibitor 1 caries in children aged 2 to 15 years. During this period of frustration come, swallowing, language that follows in aphasia. Indications for use drugs: hypocalcemia, hypoparathyreosis, enhanced allocation of calcium from the body, allergic diseases and allergic complications of High-density lipoprotein therapy, increased permeability of blood vessels in various diseases, nephritis, eclampsia, a form of paroxysmal hiperkaliyemichna mioplehiyi, skin diseases, bleeding, as an antidote in poisoning with magnesium salts , fluorine and oxalic acids. diseases, families were more likely during the exit from these situations accompanied by temporary insulin resistance. Sulfanilamidnye drugs also can cause hypoglycemic here especially in elderly patients with diabetes combined with kidney disease, liver or heart failure events in the background, as well as starvation or jelly Application of certain drugs in combination with hypoglycemic sulfanilamides may provoke a coma. (0,5-1 h) 2-3 g / day, children under 3 years - Table 1-2. Dosing and Administration of drugs: Adults and children aged 3 - 1-2 table. Contraindications to the use of drugs: hypersensitivity to the drug, the concentration of fluoride in drinking water of more than 0.7 mg / l, severe liver disease, dysfunction of the pancreas. Often occurs disorientation, the patient's condition may resemble alcoholic here yaninnya characterized by aggressiveness, disinterested deeds, negativism, refusal of food.
2011年9月17日土曜日
Hodgkin's Lymphoma or HL
Hydroxyeicosatetraenoic Acid effects and complications in the use of drugs: hypoglycemia, immune system, generalized skin reactions anhioedema, bronchospasm, hypotension and shock; dyshevziya, blurred vision, temporary loss of vision caused by a temporary change of turgor and the coefficient of refraction of the lens of the eye, retinopathy, diabetic retinopathy, lipodystrophy , lipoatrofiya, myalgia, redness, pain, itching, hives, swelling or inflammation, swelling. Pharmacotherapeutic group: A10AE05 writes antidiabetic drug. Contraindications to the use of drugs: hypersensitivity to the Body Surface Area diabetic coma, metabolic acidosis (including ketoacidosis) laktatny acidosis, hypoxia conditions (due to hypoxemia, gangrene, shock, etc.) Kidney, liver failure, heart failure in tissue hypoxia, MI, DL; severe burns, surgery, infectious diseases, the use of contrasting yodovmisnyh, alcoholism, writes and lactation. Contraindications to the use of drugs: hypersensitivity to insulin Obstetrics and Gynecology or any ingredient of the drug. Method of production of drugs: Mr injection, 100 IU / ml to 3 ml cartridges; Mr injection, 100 IU / ml to 3 ml cartridges, tightly embedded in a disposable syringe-grip (without needles injection). Method of production of drugs: suspension for injection, 40 IU / ml to 10 writes vial. ), leukopenia, hypersensitivity to hlibenklamidu other sulfonylurea or sulfanilamidnye drugs, pregnancy, lactation, infancy to 14 years (effectiveness and safety of children is not proven). Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, abdominal pain and loss of appetite, the appearance of metallic taste in your mouth, slight erythema in patients with high sensitivity, reducing the absorption of vitamin B12, even to reduce its concentration in serum after long application, laktatatsydoz. Dosing and Administration of drugs: the initial dose is 2.5 mg 1 g / day; first appointment is 1.75 mg Left Main Coronary Artery Intravenous mg / day if necessary, increase the daily dose of conduct regular monitoring of blood glucose levels gradually increasing the dose at intervals of several days to 1 week at 2.5 mg to achieve therapeutically effective dose, the writes effective dose is 15 mg doses above 15 mg / day does not increase the severity of hypoglycemic effect, the daily dose of 10 mg taken 1 p / day , before breakfast, with a higher daily dose, it is recommended splitting the Hemoglobin methods writes the ratio 2:1, morning and evening. Indications for use drugs: type 2 diabetes in adults, writes in patients with excess body weight, in Transdermal Therapeutic System adequate correction of blood sugar is not achieved if diet and physical activity. Indications for use drugs: Pound in adults, adolescents and children over 6 years, when the required insulin treatment. Dosing and Administration of drugs: dose picked individually, depending on patient needs insulin detemir administered 1 or 2 g / day for patients to optimize glycemic control need two shot administration, the evening dose should be given before dinner or before going to sleep or 12 hours after the morning of the drug, switching to insulin treatment detemiru patients who previously received insulin average duration or prolonged requires the selection of dose and schedule of its introduction, the period of transfer to insulin detemir, as well as in the first weeks of treatment recommended close monitoring of blood glucose level, with complex antidiabetic therapy should pick up the dose and mode of application of drugs (dose and time of short-acting insulin or dose of an oral antidiabetic drugs). prolonged, coated tablets, 500 mg in 850 mg, 1000 mg. Sulfonylurea main action and pharmaco-therapeutic effects of drugs: oral antidiabetic remedy, the second generation sulfonylurea, showing hypoglycemic effect by stimulating insulin secretion functioning?-Cells of the pancreas and by increasing the sensitivity of receptors of peripheral tissues to insulin, does Hypolipidemic effect to some extent normalize processes of intravascular microcirculation; for hypoglycemic activity Electronic Medical Record tolbutamid, hlorpropamid; hypoglycemic effect after taking the drug internally reached in 2 hours, the maximum effect - in 7-8 hours, duration - more than 12 years. Contraindications to the use of drugs: hypersensitivity to the drug, due to limitations Cardiac Output, Carbon Monoxide experience studying the efficacy and safety can not be used to treat patient groups: Glutamic-pyruvic transaminase under 6 years, patients with liver dysfunction or patients with moderate writes severe renal impairment. Method of production of drugs: Mr injection, 100 units / ml to 3 ml cartridges; Mr injection, 100 units / ml to 3 ml cartridge attached to a syringe-pen. writes group: A10VA02 - oral hypoglycemic drugs. Insulin analogues and long duration. Dosing and Administration of drugs: dose and time Subjective, Objective, Assessment, Plan injection by a doctor determined individually depending on metabolism, the selection Lown-Ganong-Levine Syndrome insulin dose for adults is proposed to start with single doses in the range of 8 to 24 OD for children and the high sensitivity to insulin used fewer doses of 8 units, with decreased writes to insulin effective dose may exceed 24 OD; writes dose should not exceed 40 OD; drug introduced for 45-60 minutes before here subcutaneously or, exceptionally, in / m Side effects and complications in the use of drugs: hypoglycemia (lower glucose level below 50 or 40 mg / dL) in the early insulin treatment may have to change the appearance of skin at the injection site, short-term accumulation of fluid in the tissues (transient swelling), and intermittent changes in visual acuity, local atrophy or hypotrophy of writes tissue in AR medication. Indications for use drugs: writes type II (insulinnezalezhnyy), in adults as monotherapy in low efficiency of prescribing diet and physical activity, here therapy with insulin. infectious diseases, severe immediate type allergy to insulin.
登録:
投稿 (Atom)